Author:
Peng Ya,Li Xiangsheng,Liu Huowang,Deng Xiaowen,She Chang,Liu Chenxi,Wang Xinxing,Liu An
Abstract
Abstract
Objectives
Nasopharyngeal carcinoma (NPC) is a type of nasopharyngeal disease with high metastasis and invasion properties. Tumor-associated alternative activated (M2) macrophages are evidenced to connect with NPC. Based on this, this study purposes to explore the mechanism and participation of microRNA-18a (miR-18a) from M2 macrophages in NPC.
Methods
Peripheral blood mononuclear cells were differentiated to macrophages and macrophages were polarized to M2 type by interleukin-4. SUNE-1 and CNE2 cells were transfected with restored or depleted miR-18a or transforming growth factor-beta III receptor (TGFBR3) to explore their roles in NPC progression with the involvement of the TGF-β signaling pathway. Next, SUNE-1 and CNE2 cells were co-cultured with M2 macrophages that had been treated with restored or depleted miR-18a or TGFBR3 to comprehend their combined roles in NPC with the involvement of the TGF-β signaling pathway.
Results
MiR-18a was highly expressed and TGFBR3 was lowly expressed in NPC cells. MiR-18a restoration, TGFBR3 knockdown or co-culture with miR-18a mimics, or si-TGFBR3-transfected M2 macrophages promoted SUNE-1 cell progression, tumor growth in mice, decreased p-Smad1/t-Smad1, and elevated p-Smad3/t-Smad3. miR-18a downregulation, TGFBR3 overexpression, or co-culture with miR-18a inhibitors or OE-TGFBR3-transfected M2 macrophages depressed CNE2 cell progression, tumor growth in mice, increased p-Smad1/t-Smad1, and decreased p-Smad3/t-Smad3.
Conclusion
Our study elucidates that miR-18a from M2 macrophages results in promoted NPC cell progression and tumor growth in nude mice via TGFBR3 repression, along with the Smad1 inactivation and Smad3 activation.
Funder
Hunan Province Science and Technology Foundation
Hunan provincial health and health commission Foundation
Publisher
Springer Science and Business Media LLC
Subject
Condensed Matter Physics,General Materials Science
Reference35 articles.
1. Wang S, Claret FX, Wu W (2019) MicroRNAs as therapeutic targets in nasopharyngeal carcinoma. Front Oncol 9:756
2. Batawi H, Micieli JA (2019) Nasopharyngeal carcinoma presenting as a sixth nerve palsy and Horner's syndrome. BMJ Case Rep 12:10
3. Lei, F., T. Lei, Y. Huang, M. Yang, M. Liao, and W. Huang, Radio-susceptibility of nasopharyngeal carcinoma: focus on Epstein-Barr virus, MICRORNAS, long non-coding RNAs and circular RNAs. Curr Mol Pharmacol, 2019.
4. Mai S, Xiao R, Shi L, Zhou X, Yang T, Zhang M, Weng N, Zhao X, Wang R, Liu J, Sun R, Qin H, Wang H (2019) MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma. Cell Death Dis 10(11):819
5. Chen X, Wang J, Cheng L, Lu MP (2014) miR-18a downregulates DICER1 and promotes proliferation and metastasis of nasopharyngeal carcinoma. Int J Clin Exp Med 7(4):847–855
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献